Persona Partial Knee Replacement for Osteoarthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to gather data on the effectiveness of the Persona Partial Knee system, a type of knee implant, for individuals with osteoarthritis. The focus is on the implant's longevity and overall effectiveness. It suits those with osteoarthritis severe enough to consider knee replacement surgery. Participants should not have other joint diseases, infections, or conditions affecting knee stability. As an unphased trial, participation offers a chance to contribute to valuable research that could enhance future knee implant treatments.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Persona Partial Knee system is safe for osteoarthritis?
Research shows that the Persona Partial Knee system is generally safe and well-tolerated. Studies have found that using this system for knee joint repair or replacement yields good results with few complications. Specifically, the Persona Knee implant system demonstrated safety and effectiveness in similar procedures, achieving a 99% success rate over two years with only one follow-up surgery required to fix or replace the implant.
Additionally, patients using the Persona Partial Knee system reported improved knee function, scoring higher on tests measuring knee health and recovery. This indicates that the system not only performs well but is also safe to use. Overall, the evidence supports the safety of the Persona Partial Knee system for those considering this treatment.12345Why are researchers excited about this trial?
Unlike the standard knee replacement surgeries that often involve replacing the entire knee joint, the Persona Partial Knee system offers a more targeted approach for osteoarthritis. This system is designed to replace only the damaged part of the knee, preserving healthy bone and tissue. Researchers are excited about this treatment because it can potentially lead to a quicker recovery, less pain, and more natural movement compared to a total knee replacement. By focusing on the specific area affected by osteoarthritis, the Persona Partial Knee system aims to offer a personalized fit and improved function, making it a promising option for patients with localized knee issues.
What evidence suggests that the Persona Partial Knee system is effective for osteoarthritis?
Research has shown that the Persona Partial Knee system, which participants in this trial will receive, holds promise for treating osteoarthritis. This system, used in knee replacements, has been linked to better patient-reported outcomes compared to other implants. It incorporates design features from an earlier knee implant that achieved a 98% success rate after 10 years and 90% after 20 years. Clinical data up to two years post-surgery indicate high patient satisfaction and effective performance. These findings suggest that the Persona Partial Knee system could be a reliable choice for those needing knee replacement due to osteoarthritis.12367
Who Is on the Research Team?
Hillary Overholser
Principal Investigator
Zimmer Biomet
Are You a Good Fit for This Trial?
This trial is for adults over 18 who need a knee replacement due to conditions like osteoarthritis or tibial plateau fracture and are suitable for the Persona Partial Knee system. Participants must be able to follow the study plan and give informed consent. Those with severe bone or joint issues, certain neurological disorders, infections, inflammatory diseases, or pregnant women cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Evaluation
Participants undergo preoperative clinical evaluations prior to their partial knee arthroplasty
Treatment
Participants receive the Persona Partial Knee system
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Follow-up
Optional continuation of follow-up assessment up to 10 years
What Are the Treatments Tested in This Trial?
Interventions
- Persona Partial Knee system
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zimmer Biomet
Lead Sponsor
Dr. Nitin Goyal
Zimmer Biomet
Chief Medical Officer since 2021
MD from Harvard Medical School
Ivan Tornos
Zimmer Biomet
Chief Executive Officer since 2023
MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business